PHARMA-BIO SERV, INC. (PBSV) Operating margin 2017–2025
PHARMA-BIO SERV, INC. (PBSV) operating margin by fiscal year — reported operating income divided by reported revenue.
-7.1%FY2025 · since FY2017: -5.8% → -7.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -7.1% | +6.5 pp |
| FY2024 | -13.5% | -20.1 pp |
| FY2023 | 6.6% | +0.5 pp |
| FY2022 | 6.1% | +25.2 pp |
| FY2021 | -19.2% | -29.5 pp |
| FY2020 | 10.3% | +1.6 pp |
| FY2019 | 8.7% | +15.8 pp |
| FY2018 | -7.1% | -1.2 pp |
| FY2017 | -5.8% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice